Lexicon Pharmaceuticals LXRX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's quick ratio?
- Lexicon Pharmaceuticals (LXRX) reported quick ratio of 18.8× in Q1 2026.
- How has Lexicon Pharmaceuticals's quick ratio changed year-over-year?
- Lexicon Pharmaceuticals's quick ratio increased by 745.8% year-over-year, from 2.2× to 18.8×.
- What is the long-term trend for Lexicon Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's quick ratio has grown at a 7.6% compound annual growth rate (CAGR), from 3.4× to 4.9×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.